CXR Drug Discovery

CXR Biosciences is a specialist contract research organization (CRO) and drug discovery company based in Dundee, Scotland. Spun out from the University of Dundee in 2001, the company provides high-value investigative toxicology, exploratory toxicology, and ADME services to the pharmaceutical and chemical industries. CXR is known for its expertise in nuclear receptors and its Reverse Drug Discovery approach, which leverages existing toxicity data to identify new therapeutic opportunities. In 2015, the company was acquired by Concept Life Sciences, where it continues to operate as a center of excellence for toxicology and preclinical discovery services.